Clinical and Whole-Exome Sequencing Findings in Individuals From
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Supplementary Materials: Evaluation of Cytotoxicity and Α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids
Supplementary Materials: Evaluation of cytotoxicity and α-glucosidase inhibitory activity of amide and polyamino-derivatives of lupane triterpenoids Oxana B. Kazakova1*, Gul'nara V. Giniyatullina1, Akhat G. Mustafin1, Denis A. Babkov2, Elena V. Sokolova2, Alexander A. Spasov2* 1Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences, 71, pr. Oktyabrya, 450054 Ufa, Russian Federation 2Scientific Center for Innovative Drugs, Volgograd State Medical University, Novorossiyskaya st. 39, Volgograd 400087, Russian Federation Correspondence Prof. Dr. Oxana B. Kazakova Ufa Institute of Chemistry of the Ufa Federal Research Centre of the Russian Academy of Sciences 71 Prospeсt Oktyabrya Ufa, 450054 Russian Federation E-mail: [email protected] Prof. Dr. Alexander A. Spasov Scientific Center for Innovative Drugs of the Volgograd State Medical University 39 Novorossiyskaya st. Volgograd, 400087 Russian Federation E-mail: [email protected] Figure S1. 1H and 13C of compound 2. H NH N H O H O H 2 2 Figure S2. 1H and 13C of compound 4. NH2 O H O H CH3 O O H H3C O H 4 3 Figure S3. Anticancer screening data of compound 2 at single dose assay 4 Figure S4. Anticancer screening data of compound 7 at single dose assay 5 Figure S5. Anticancer screening data of compound 8 at single dose assay 6 Figure S6. Anticancer screening data of compound 9 at single dose assay 7 Figure S7. Anticancer screening data of compound 12 at single dose assay 8 Figure S8. Anticancer screening data of compound 13 at single dose assay 9 Figure S9. Anticancer screening data of compound 14 at single dose assay 10 Figure S10. -
Analysis of Trans Esnps Infers Regulatory Network Architecture
Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation. -
General Contribution
24 Abstracts of 37th Annual Meeting A1 A SCREENING METHOD FOR FRAGILE X MUTATION: DETECTION OF THE CGG REPEAT IN FMR-1 GENE BY PCR WITH BIOTIN-LABELED PRIMER. ..Eiji NANBA, Kousaku OHNO and Kenzo TAKESHITA Division of Child Neurology, Institute of Neurological Sciences, Tot- tori University School of Medicine. Yonago We have developed a new polymerase chain reaction(PCR)-based method for detection of the CGG repeat in FMR-1 gene. No specific product from PCR was detected on the gel with ethidium bromide staining, because 7-deaza-2'-dGTP is necessary for amplification of this repeat. Biotin-labeled primer was used for PCR and the product was transferred to a nylon membrane followed the detection of biotin by Smilight kit. The size of PCR product from normal control were slightly various and around 300bp. No PCR product was detected from 3 fragile X male patients in 2 families diagnosed by cytogenetic examination. This method is useful for genetic screen- ing of male mental retardation patients to exclude the fragile X mutation. A2 DNA ANALYSISFOR FRAGILE X SYNDROME Osamu KOSUDA,Utak00GASA, ~.ideynki INH, a~ji K/NAGIJCltI, and Kazumasa ]tIKIJI (SILL Inc., Tokyo) Fragile X syndrome is X-linked disease having the amplification of (CG6)n repeat sequence in the chromsomeXq27.3. We performed Southern blot analysis using three probes recognized repetitive sequence resion. Normal controle showed 5.2Kb with Eco RI digest and 2.7Kb with Eco RI/Bss ttII digest as the germ tines by the Southern blot analysis. However, three cell lines established fro~ unrelated the patients with fragile X showed the abnormal bands between 5.2 and 7.7Kb with Eco RI digest, and between 2.7 and 7.7Kb with Eco aI/Bss HII digest. -
ZNF408 Polyclonal Antibody
PRODUCT DATA SHEET Bioworld Technology,Inc. ZNF408 polyclonal antibody Catalog: BS71268 Host: Rabbit Reactivity: Human,Mouse,Rat BackGround: by affinity-chromatography using epitope-specific im- Zinc-finger proteins contain DNA-binding domains and munogen and the purity is > 95% (by SDS-PAGE). have a wide variety of functions, most of which encom- Applications: pass some form of transcriptional activation or repression. WB 1:500 - 1:2000 The majority of zinc-finger proteins contain a Krüp- IHC 1:50 - 1:200 pel-type DNA binding domain and a KRAB domain, Storage&Stability: which is thought to interact with KAP1, thereby recruit- Store at 4°C short term. Aliquot and store at -20°C long ing histone modifying proteins. As a member of the term. Avoid freeze-thaw cycles. Krüppel C2H2-type zinc-finger protein family, ZNF396 Specificity: (zinc finger protein 396), also known as PRDM17 (PR ZNF408 polyclonal antibody detects endogenous levels domain zinc finger protein 17), is a 720 amino acid nu- of ZNF408 protein. clear protein that contains 10 C2H2-type zinc fingers. The DATA: gene encoding ZNF408 maps to human chromosome 11, which houses over 1,400 genes and comprises nearly 4% of the human genome. Jervell and Lange-Nielsen syn- drome, Jacobsen syndrome, Niemann-Pick disease, he- reditary angioedema and Smith-Lemli-Opitz syndrome are associated with defects in genes that maps to chro- mosome 11. Product: Western blot analysis of extracts of various cells, using ZNF408 anti- Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, body. 50% glycerol, pH7.2 Note: Molecular Weight: For research use only, not for use in diagnostic procedure. -
SUPPLEMENTARY MATERIAL Effect of Next
SUPPLEMENTARY MATERIAL Effect of Next-Generation Exome Sequencing Depth for Discovery of Diagnostic Variants KKyung Kim1,2,3†, Moon-Woo Seong4†, Won-Hyong Chung3, Sung Sup Park4, Sangseob Leem1, Won Park5,6, Jihyun Kim1,2, KiYoung Lee1,2*‡, Rae Woong Park1,2* and Namshin Kim5,6** 1Department of Biomedical Informatics, Ajou University School of Medicine, Suwon 443-749, Korea 2Department of Biomedical Science, Graduate School, Ajou University, Suwon 443-749, Korea, 3Korean Bioinformation Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Korea, 4Department of Laboratory Medicine, Seoul National University Hospital College of Medicine, Seoul 110-799, Korea, 5Department of Functional Genomics, Korea University of Science and Technology, Daejeon 305-806, Korea, 6Epigenomics Research Center, Genome Institute, Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Korea http//www. genominfo.org/src/sm/gni-13-31-s001.pdf Supplementary Table 1. List of diagnostic genes Gene Symbol Description Associated diseases ABCB11 ATP-binding cassette, sub-family B (MDR/TAP), member 11 Intrahepatic cholestasis ABCD1 ATP-binding cassette, sub-family D (ALD), member 1 Adrenoleukodystrophy ACVR1 Activin A receptor, type I Fibrodysplasia ossificans progressiva AGL Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase Glycogen storage disease ALB Albumin Analbuminaemia APC Adenomatous polyposis coli Adenomatous polyposis coli APOE Apolipoprotein E Apolipoprotein E deficiency AR Androgen receptor Androgen insensitivity -
Newfound Coding Potential of Transcripts Unveils Missing Members Of
bioRxiv preprint doi: https://doi.org/10.1101/2020.12.02.406710; this version posted December 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Newfound coding potential of transcripts unveils missing members of 2 human protein communities 3 4 Sebastien Leblanc1,2, Marie A Brunet1,2, Jean-François Jacques1,2, Amina M Lekehal1,2, Andréa 5 Duclos1, Alexia Tremblay1, Alexis Bruggeman-Gascon1, Sondos Samandi1,2, Mylène Brunelle1,2, 6 Alan A Cohen3, Michelle S Scott1, Xavier Roucou1,2,* 7 1Department of Biochemistry and Functional Genomics, Université de Sherbrooke, Sherbrooke, 8 Quebec, Canada. 9 2 PROTEO, Quebec Network for Research on Protein Function, Structure, and Engineering. 10 3Department of Family Medicine, Université de Sherbrooke, Sherbrooke, Quebec, Canada. 11 12 *Corresponding author: Tel. (819) 821-8000x72240; E-Mail: [email protected] 13 14 15 Running title: Alternative proteins in communities 16 17 Keywords: alternative proteins, protein network, protein-protein interactions, pseudogenes, 18 affinity purification-mass spectrometry 19 20 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.12.02.406710; this version posted December 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 21 Abstract 22 23 Recent proteogenomic approaches have led to the discovery that regions of the transcriptome 24 previously annotated as non-coding regions (i.e. -
Supporting Information
Supporting Information Collin et al. 10.1073/pnas.1220864110 SI Materials and Methods Mutation Analysis of PASK and ZNF408. The two candidate variants Human Subjects. A detailed clinical description of familial exudative that were left after linkage and exome analysis were analyzed in vitreoretinopathy (FEVR) family W05-215 has been reported family W05-215 with Sanger sequencing of exon 6 of proline- previously (1), and clinical details of the affected individuals alanine-rich ste20-related kinase (PASK) and exon 5 of zinc studied using next-generation sequencing (NGS) (III:5 and V:2) finger protein 408 (ZNF408). Primer sequences are available are summarized below. Eight affected individuals, three un- on request. The presence of these two changes in additional affected individuals, and three spouses participated in the ge- Dutch FEVR probands and 110 control individuals was ana- netic analysis (Fig. S1A). After linkage and exome sequencing lyzed via restriction fragment length polymorphism analysis, analysis were performed, three additional affected relatives using AflIII for the c.791dup change in PASK and SfaNI for the (IV:10, IV:11, and V:7) were sampled. Clinical details of the c.1363C>T change in ZNF408. All exons and intron–exon two individuals with FEVR from family W05-220 (IV:3 and boundaries of ZNF408 were amplified under standard PCR V:2) are summarized below. Furthermore, 132 individuals with conditions using primers that are available on request. Sanger FEVR (8 from The Netherlands, 64 from the United Kingdom, sequence analysis was performed with the ABI PRISM Big Dye 55 from Japan, and 5 from Switzerland) participated in this Terminator Cycle Sequencing V2.0 Ready Reaction Kit and study, along with 110 ethnically matched Dutch and 191 eth- an ABI PRISM 3730 DNA analyzer (Applied Biosystems). -
Opthalmic Genetics
Inherited Genetics Opthalmic Genetics What is Opthalmic Genetics? Developmental • Anterior segment dysgenesis Of the approximately 5000 genetic diseases and syndromes known to affect humans, at • Aniridia least one-third involve the eye. Due to advances in molecular genetics and sequencing • Anophthlamos/ microphthalmos/ nanophthalmos methods, there has been an exponential increase in the knowledge of genetic eye diseases and syndromes. • Coloboma Complex Prevalence • Cataract • Keratoconus • More than 60% of cases of blindness among infants are caused by inherited eye • Fuchs endothelial corneal dystrophy diseases such as congenital cataracts, congenital glaucoma, retinal degeneration, • Age-related macular degeneration optic atrophy, eye malformations and corneal dystrophies. • Glaucoma • Pseudoexfoliation syndrome What are the common Genetic Opthalmic • Diabetic retinopathy Disorders ? Why do you need to test for Genetic Ophthalmic Disorders can be classified according to the type of genetic abnormality Opthalmic Disorders? Monogenic • There is also evidence now that the most common vision problems among children and adults are genetically determined (Eg: strabismus, amblyopia, refractive errors • Corneal dystrophies such as myopia, hyperopia and astigmatism) • Oculocutaneous Albinism • Genetic ophthalmic disorders include a large number of ocular pathologies which • Norrie disease have autosomal dominant, autosomal recessive or X-linked inheritance patterns, or • Retinoschisis are complex traits with polygenic and environmental components -
Defects in the Cell Signaling Mediator Β-Catenin Cause the Retinal Vascular Condition FEVR
This is a repository copy of Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/117491/ Version: Accepted Version Article: Panagiotou, ES, Sanjurjo Soriano, C, Poulter, JA orcid.org/0000-0003-2048-5693 et al. (15 more authors) (2017) Defects in the Cell Signaling Mediator β-Catenin Cause the Retinal Vascular Condition FEVR. The American Journal of Human Genetics, 100 (6). pp. 960-968. ISSN 0002-9297 https://doi.org/10.1016/j.ajhg.2017.05.001 © 2017, American Society of Human Genetics. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ 1 Defects in the cell signaling mediator -catenin cause the retinal vascular 2 condition FEVR 3 4 Evangelia S. -
Genetic Investigation of 211 Chinese Families Expands the Mutational and Phenotypical Spectrum in Hereditary Retinopathy Genes Through Targeted Sequencing Technology
Genetic investigation of 211 Chinese families expands the mutational and phenotypical spectrum in hereditary retinopathy genes through targeted sequencing technology Zhouxian Bai The First Aliated Hospital of Zhengzhou University https://orcid.org/0000-0001-7071-666X Yanchuan Xie First Aliated Hospital of Henan University of Science and technology Lina Liu First Aliated Hospital of Zhengzhou University Jingzhi Shao Southern Medical University Nanfang Hospital Yuying Liu First Aliated Hospital of Zhengzhou University Xiangdong Kong ( [email protected] ) https://orcid.org/0000-0003-0030-7638 Research article Keywords: hereditary retinopathy, novel mutations, targeted sequencing, genetic testing Posted Date: December 4th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-20958/v2 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published at BMC Medical Genomics on March 29th, 2021. See the published version at https://doi.org/10.1186/s12920-021-00935-w. Page 1/22 Abstract Background: Hereditary retinopathy is a signicant cause of blindness worldwide. Despite the discovery of many mutations in various retinopathies, a large part of patients remain undiagnosed genetically. Targeted next generation sequencing of the human genome is a suitable approach for retinopathy molecular diagnosis. Methods: We described a cohort of 211 families from central China with various forms of retinopathy, 95 families of which were investigated using NGS multi-gene panel sequencing as well as the other 116 patients were LHON suspected tested by Sanger sequencing. We validated the candidate variants by PCR- based Sanger sequencing. We have made comprehensive analysis of the cases through sequencing data and ophthalmologic examination information. -
Neurology, Neuromuscular, and Cardiology Disorders
GENETIC TESTING SOLUTIONS FOR: NEUROLOGY, NEUROMUSCULAR, AND CARDIOLOGY DISORDERS EGL Genetics has nearly 50 years of genetic testing history built upon a strong academic foundation. Our expertise spans common and rare genetic disease testing, genomic variant interpretation, test development and research. As we have grown, we have evolved into a high-science and high-performing CLIA-certifi ed and CAP-accredited laboratory with over 1,100 test offerings across biochemical genetics, cytogenetics, and molecular genetic testing. COMPREHENSIVE OFFERINGS There are signifi cant genetic and phenotypic heterogeneity for disorders involving neurology, neuromuscular, and cardiovascular systems, and obtaining a specifi c diagnosis is important for prognosis, patient management, and development of therapeutic strategies. Consider this collection of test offerings for patients with heart disease, intellectual disability, autism spectrum disorders, movement disorders, epilepsy, and more. Identifi cation of a causative genetic defect may provide information for prognosis and therapeutic intervention, and is required for carrier testing and early prenatal diagnosis. TEST OFFERINGS FOR THE FOLLOWING CLINICAL INDICATIONS: • Cardiomyopathy and cardiovascular diseases • Autism and intellectual disabilities • Neuromuscular disorders and muscular dystrophy • Epilepsy • Movement disorders ADVANTAGES OF PARTNERING WITH EGL GENETICS: • Board-certifi ed laboratory directors & genetic counselors to answer clinical and analytical questions • Multiple sample collection -
Pre-Implantation Genetic Diagnosis and Assisted Reproductive Technology in Haemophilia
PRE-IMPLANTATION GENETIC DIAGNOSIS AND ASSISTED REPRODUCTIVE TECHNOLOGY IN HAEMOPHILIA DR PENELOPE FOSTER MELBOURNE IVF WHAT IS PGD ? early embryo diagnosis allows selection of unaffected embryos for transfer to patient alternative to antenatal testing and termination of affected pregnancy MELBOURNE IVF TECHNIQUE OF PGD standard IVF cycle biopsy of 1 or 2 cells from day 3 embryo diagnostic testing on biopsied cells selection of embryos for transfer MELBOURNE IVF PGD IN HAEMOPHILIA OPTIONS Sex selection: if affected husband, all male offspring unaffected, all females carriers = select male embryos for transfer if carrier wife, 1/2 males affected, 1/2 females carrier = select female embryos for transfer MELBOURNE IVF PGD IN HAEMOPHILIA OPTIONS Specific gene detection avoids discarding unaffected male embryos avoids transfer of carrier female embryos MELBOURNE IVF SEX SELECTION - FISH FLUORESCENT IN-SITU HYBRIDISATION detects chromosome number cell from embryo fixed to slide apply FISH probes DNA sequences complementary to small segment of particular chromosome probes labelled with coloured fluorochromes coloured spots indicate presence of sequence 8-probe FISH – chromosomes 4,13,16,18,21,22,X,Y select euploid XX or XY embryos for transfer MELBOURNE IVF FISH ON BLASTOMERES 13, 16, 18, 21, 22 X, Y, 4 MELBOURNE IVF XX XY MELBOURNE IVF PGD FOR SPECIFIC GENE DETECTION DNA amplification by PCR 2 cells from embryo fragment analysis on DNA sequencer inclusion of informative markers individualised tests for each couple significant